Synthace's purpose is universal bioscience productivity. Our deceptively simple bio-programming language, Antha is bioscience’s missing link.
Antha effortlessly spreads biological information in a repeatable way, easily linking laboratory equipment, protocols and processes to bring Design for Manufacturing to bioengineering.
The company works with international businesses such as Merck & Co. and Dow AgroSciences to develop high productivity bioprocess’s to make bio-based products, and with equipment vendors such as Gilson and CyBio to implement Antha software tools for automation.
By linking everything Antha allows vast and speedy optimization, enhancing productivity for any bioscience from pure research to volume manufacture.
New synthetic biology technologies are starting to offer exciting opportunities across a range of industries including manufacturing, pharmaceuticals, biofuels and health.
Research Council funding in collaboration with a wide variety of national and international partners across academia and industry, is supporting the long-term growth of UK synthetic biology, development of a highly skilled workforce and an infrastructure to underpin and enable cutting edge research in industry and academia, as well as providing support for synthetic biology start-up companies.
The pervasive potential of synthetic biology is brought to life through a series of case studies ranging from a biosensor toolkit with the ability to treat chronic conditions such as diabetes through to using enzymes from yeast mould to unlock cleaner routes to producing biofuel.
The wide ranging applications of synthetic biology will play an important role in growing the UK's bioeconomy, creating new jobs and ensuring the UK is a world leader in this area.